STOP THE BIG PHARMA MONEY GRAB: REJECT SENATE BILL 62

Senate Bill 62 Would Hike Health Care Costs for New Mexico Families, Employers, and Unions by More Than $97 Million Every Year

Senate Bill 62 is a Big Pharma-backed proposal that would ban pay-for-performance incentives in the private health care marketplace—eliminating a key tool that employers and unions use to lower prescription drug costs for hardworking New Mexicans.

This bill is a $97 million annual giveaway to Big Pharma at the direct expense of New Mexico patients, employers and unions. Instead of lowering the cost of prescription drugs, it undermines market-based savings, drives up insurance premiums and increases out-of-pocket costs for over 800,000 New Mexicans who rely on employer or union-provided health coverage

What Senate Bill 62 Would Do:

Increase Health Care Costs for 800,000+ New Mexicans

Reward Big Pharma at the Expense of New Mexican Families

Do Nothing to Lower Prescription Drug Prices

Employers and unions negotiate better deals on prescription drugs through voluntarily choosing to hire pharmacy benefit managers (PBMs), critical members of the health care system that pool their negotiating power to unlock savings for health plan sponsors, and the patients and families on these plans.

Senate Bill 62 would ban pay-for-performance incentives in the private health care marketplace that are essential for New Mexico employers and unions to secure significant savings on prescription drugs, directly leading to higher premium costs for patients.

This bill is not about protecting patients—it’s about protecting Big Pharma’s profits.

Tell Your Legislators: Vote NO on Senate Bill 62

New Mexicans can’t afford a bill that increases health care costs while doing nothing to lower prescription drug prices. Contact your legislators today and tell them to reject Senate Bill 62.